|
⚲
|
| Keyboard |
| Cole Hugh M
✚
|
|
|---|---|
| CIK # | 0001604646 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001604646] | |
| 4 | [0001604646] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cole Hugh M | |
| Catabasis Pharmaceuticals Inc | |
| Jounce Therapeutics Inc | |
| Ariad Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 16,666 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 26,550 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 14,100 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 14,100 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2023-01-10 | Sell | 9,182 | $1.12 | 10,284 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2023-01-09 | Sell | 7,452 | $1.10 | 8,197 |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2022-08-01 | Grant | 40,000 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2022-08-01 | Grant | 20,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 8,333 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2022-02-01 | Grant | 85,000 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2022-02-01 | Grant | 42,500 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2022-01-10 | Sell | 6,205 | $6.65 | 41,263 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2022-01-07 | Sell | 3,468 | $7.30 | 25,316 |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2021-06-02 | Grant | 100,000 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2021-02-01 | Grant | 53,400 | $11.89 | 634,926 |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2021-02-01 | Grant | 26,700 | $0.00 | |
| showing 20 of 72 most recent transactions | |||||